{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:45:03Z","timestamp":1794955503635,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Infiltration of macrophages into tumors is a hallmark of cancer progression, and re-educating tumor-associated macrophages (TAMs) toward an antitumor status is a promising immunotherapy strategy. However, the mechanisms through which cancer cells affect macrophage education are unclear, limiting the therapeutic potential of this approach. Here we conducted an unbiased genome-wide CRISPR screen of primary macrophages. Our study confirms the function of known regulators in TAM responses and reveals new insights into the behavior of these cells. We identify olfactory and vomeronasal receptors, or chemosensors, as important drivers of a tumor-supportive macrophage phenotype across multiple cancers. In vivo deletion of selected chemosensors in TAMs resulted in cancer regression and increased infiltration of tumor-reactive CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells. In human prostate cancer tissues, palmitic acid bound to olfactory receptor 51E2 (OR51E2) expressed by TAMs, enhancing their protumor phenotype. Spatial lipidomics analysis further confirmed the presence of palmitic acid in close proximity to TAMs in prostate cancer, supporting the function of this lipid mediator in the tumor microenvironment. Overall, these data implicate chemosensors in macrophage sensing of the lipid-enriched milieu and highlight these receptors as possible therapeutic targets for enhancing antitumor immunity.\n                  <\/jats:p>","DOI":"10.1038\/s41590-025-02191-x","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T11:02:14Z","timestamp":1751281334000},"page":"1182-1197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Chemosensor receptors are lipid-detecting regulators of macrophage function in cancer"],"prefix":"10.1038","volume":"26","author":[{"given":"Giulia","family":"Marelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Morina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4007-4365","authenticated-orcid":false,"given":"Simone","family":"Puccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Iovino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Portale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Carvetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Diana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Meregalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvezia","family":"Paraboschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Cibella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia","family":"Peano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Camisaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Magrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiuseppe","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4411-3715","authenticated-orcid":false,"given":"Massimo","family":"Lazzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Morosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5963-4580","authenticated-orcid":false,"given":"Giuseppe","family":"Martano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Asselta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bonavita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiro","family":"Matsunami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5637-8983","authenticated-orcid":false,"given":"Francesco","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8771-2577","authenticated-orcid":false,"given":"Logan","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1964-7678","authenticated-orcid":false,"given":"Enrico","family":"Lugli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-4259","authenticated-orcid":false,"given":"Diletta","family":"Di Mitri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"2191_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani, A., Allavena, P., Marchesi, F. & Garlanda, C. Macrophages as tools and targets in cancer therapy. Nat. Rev. Drug Discov. 21, 799\u2013820 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2191_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1126\/science.abg3067","volume":"375","author":"M Orecchioni","year":"2022","unstructured":"Orecchioni, M. et al. Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. Science 375, 214\u2013221 (2022).","journal-title":"Science"},{"key":"2191_CR3","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1126\/science.1080376","volume":"299","author":"M Spehr","year":"2003","unstructured":"Spehr, M. et al. Identification of a testicular odorant receptor mediating human sperm chemotaxis. Science 299, 2054\u20132058 (2003).","journal-title":"Science"},{"key":"2191_CR4","doi-asserted-by":"publisher","first-page":"e55368","DOI":"10.1371\/journal.pone.0055368","volume":"8","author":"C Flegel","year":"2013","unstructured":"Flegel, C., Manteniotis, S., Osthold, S., Hatt, H. & Gisselmann, G. Expression profile of ectopic olfactory receptors determined by deep sequencing. PLoS ONE 8, e55368 (2013).","journal-title":"PLoS ONE"},{"key":"2191_CR5","doi-asserted-by":"publisher","first-page":"C502","DOI":"10.1152\/ajpcell.00454.2019","volume":"318","author":"K Kotlo","year":"2020","unstructured":"Kotlo, K. et al. The olfactory G protein-coupled receptor (Olfr-78\/OR51E2) modulates the intestinal response to colitis. Am. J. Physiol. Cell Physiol. 318, C502\u2013C513 (2020).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2191_CR6","doi-asserted-by":"publisher","first-page":"e80148","DOI":"10.1371\/journal.pone.0080148","volume":"8","author":"JJ Li","year":"2013","unstructured":"Li, J. J. et al. Activation of olfactory receptors on mouse pulmonary macrophages promotes monocyte chemotactic protein-1 production. PLoS ONE 8, e80148 (2013).","journal-title":"PLoS ONE"},{"key":"2191_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-024-08126-0","volume":"635","author":"CA de March","year":"2024","unstructured":"de March, C. A. et al. Engineered odorant receptors illuminate the basis of odour discrimination. Nature 635, 499\u2013508 (2024).","journal-title":"Nature"},{"key":"2191_CR8","doi-asserted-by":"publisher","first-page":"100475","DOI":"10.1016\/j.jbc.2021.100475","volume":"296","author":"A Pronin","year":"2021","unstructured":"Pronin, A. & Slepak, V. Ectopically expressed olfactory receptors OR51E1 and OR51E2 suppress proliferation and promote cell death in a prostate cancer cell line. J. Biol. Chem. 296, 100475 (2021).","journal-title":"J. Biol. Chem."},{"key":"2191_CR9","doi-asserted-by":"crossref","unstructured":"Vadevoo, S. M. P. et al. The macrophage odorant receptor Olfr78 mediates the lactate-induced M2 phenotype of tumor-associated macrophages. Proc. Natl Acad. Sci. USA 118, e2102434118 (2021).","DOI":"10.1073\/pnas.2102434118"},{"key":"2191_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cell.2015.06.059","volume":"162","author":"O Parnas","year":"2015","unstructured":"Parnas, O. et al. A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks. Cell 162, 675\u2013686 (2015).","journal-title":"Cell"},{"key":"2191_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj4008","volume":"375","author":"R Schmidt","year":"2022","unstructured":"Schmidt, R. et al. CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science 375, eabj4008 (2022).","journal-title":"Science"},{"key":"2191_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41586-021-04109-7","volume":"600","author":"L Long","year":"2021","unstructured":"Long, L. et al. CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity. Nature 600, 308\u2013313 (2021).","journal-title":"Nature"},{"key":"2191_CR13","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1182\/blood.2022015646","volume":"140","author":"M Chiba","year":"2022","unstructured":"Chiba, M. et al. Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas. Blood 140, 1951\u20131963 (2022).","journal-title":"Blood"},{"key":"2191_CR14","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.cell.2018.10.024","volume":"175","author":"E Shifrut","year":"2018","unstructured":"Shifrut, E. et al. Genome-wide CRISPR screens in primary human T cells reveal key regulators of immune function. Cell 175, 1958\u20131971.e1915 (2018).","journal-title":"Cell"},{"key":"2191_CR15","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ccell.2022.06.001","volume":"40","author":"JA Belk","year":"2022","unstructured":"Belk, J. A. et al. Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence. Cancer Cell 40, 768\u2013786.e767 (2022).","journal-title":"Cancer Cell"},{"key":"2191_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41255-0","volume":"14","author":"D Dervovic","year":"2023","unstructured":"Dervovic, D. et al. Author correction: in vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer. Nat. Commun. 14, 5404 (2023).","journal-title":"Nat. Commun."},{"key":"2191_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-022-00802-4","volume":"23","author":"H Shi","year":"2023","unstructured":"Shi, H., Doench, J. G. & Chi, H. CRISPR screens for functional interrogation of immunity. Nat. Rev. Immunol. 23, 363\u2013380 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"2191_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108541","volume":"33","author":"S Covarrubias","year":"2020","unstructured":"Covarrubias, S. et al. High-throughput CRISPR screening identifies genes involved in macrophage viability and inflammatory pathways. Cell Rep. 33, 108541 (2020).","journal-title":"Cell Rep."},{"key":"2191_CR19","doi-asserted-by":"publisher","first-page":"e1011058","DOI":"10.1371\/journal.ppat.1011058","volume":"19","author":"RC Glover","year":"2023","unstructured":"Glover, R. C. et al. A genome-wide screen in macrophages identifies PTEN as required for myeloid restriction of Listeria monocytogenes infection. PLoS Pathog. 19, e1011058 (2023).","journal-title":"PLoS Pathog."},{"key":"2191_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35604-8","volume":"13","author":"J Shi","year":"2022","unstructured":"Shi, J. et al. A genome-wide CRISPR screen identifies WDFY3 as a regulator of macrophage efferocytosis. Nat. Commun. 13, 7929 (2022).","journal-title":"Nat. Commun."},{"key":"2191_CR21","doi-asserted-by":"crossref","unstructured":"Yeung, A. T. Y. et al. A genome-wide knockout screen in human macrophages identified host factors modulating Salmonella infection. mBio 10, e02169-19 (2019).","DOI":"10.1128\/mBio.02169-19"},{"key":"2191_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-023-06685-2","volume":"623","author":"N Caronni","year":"2023","unstructured":"Caronni, N. et al. IL-1\u03b2+ macrophages fuel pathogenic inflammation in pancreatic cancer. Nature 623, 415\u2013422 (2023).","journal-title":"Nature"},{"key":"2191_CR23","first-page":"7450","volume":"50","author":"R Andreesen","year":"1990","unstructured":"Andreesen, R. et al. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res. 50, 7450\u20137456 (1990).","journal-title":"Cancer Res."},{"key":"2191_CR24","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/s12276-023-01068-z","volume":"55","author":"YR Na","year":"2023","unstructured":"Na, Y. R., Kim, S. W. & Seok, S. H. A new era of macrophage-based cell therapy. Exp. Mol. Med. 55, 1945\u20131954 (2023).","journal-title":"Exp. Mol. Med."},{"key":"2191_CR25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky, M. et al. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat. Biotechnol. 38, 947\u2013953 (2020).","journal-title":"Nat. Biotechnol."},{"key":"2191_CR26","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","volume":"81","author":"NR Anderson","year":"2021","unstructured":"Anderson, N. R., Minutolo, N. G., Gill, S. & Klichinsky, M. Macrophage-based approaches for cancer immunotherapy. Cancer Res. 81, 1201\u20131208 (2021).","journal-title":"Cancer Res."},{"key":"2191_CR27","first-page":"6568","volume":"60","author":"LL Xu","year":"2000","unstructured":"Xu, L. L. et al. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res. 60, 6568\u20136572 (2000).","journal-title":"Cancer Res."},{"key":"2191_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/pros.20389","volume":"66","author":"J Wang","year":"2006","unstructured":"Wang, J. et al. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase. Prostate 66, 847\u2013857 (2006).","journal-title":"Prostate"},{"key":"2191_CR29","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1152\/physrev.00013.2017","volume":"98","author":"D Massberg","year":"2018","unstructured":"Massberg, D. & Hatt, H. Human olfactory receptors: novel cellular functions outside of the nose. Physiol. Rev. 98, 1739\u20131763 (2018).","journal-title":"Physiol. Rev."},{"key":"2191_CR30","doi-asserted-by":"crossref","unstructured":"Meijerink, J. The intestinal fatty acid-enteroendocrine interplay, emerging roles for olfactory signaling and serotonin conjugates. Molecules 26, 1416 (2021).","DOI":"10.3390\/molecules26051416"},{"key":"2191_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fonc.2018.00162","volume":"8","author":"T Abaffy","year":"2018","unstructured":"Abaffy, T. et al. A testosterone metabolite 19-hydroxyandrostenedione induces neuroendocrine trans-differentiation of prostate cancer cells via an ectopic olfactory receptor. Front. Oncol. 8, 162 (2018).","journal-title":"Front. Oncol."},{"key":"2191_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41586-022-05672-3","volume":"614","author":"M Sorin","year":"2023","unstructured":"Sorin, M. et al. Single-cell spatial landscapes of the lung tumour immune microenvironment. Nature 614, 548\u2013554 (2023).","journal-title":"Nature"},{"key":"2191_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(19)30764-0","volume":"394","author":"WD Tap","year":"2019","unstructured":"Tap, W. D. et al. Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial. Lancet 394, 478\u2013487 (2019).","journal-title":"Lancet"},{"key":"2191_CR34","doi-asserted-by":"publisher","first-page":"612","DOI":"10.5483\/BMBRep.2012.45.11.232","volume":"45","author":"N Kang","year":"2012","unstructured":"Kang, N. & Koo, J. Olfactory receptors in non-chemosensory tissues. BMB Rep. 45, 612\u2013622 (2012).","journal-title":"BMB Rep."},{"key":"2191_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/hmg\/11.5.535","volume":"11","author":"JM Young","year":"2002","unstructured":"Young, J. M. et al. Different evolutionary processes shaped the mouse and human olfactory receptor gene families. Hum. Mol. Genet. 11, 535\u2013546 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"2191_CR36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nn800","volume":"5","author":"X Zhang","year":"2002","unstructured":"Zhang, X. & Firestein, S. The olfactory receptor gene superfamily of the mouse. Nat. Neurosci. 5, 124\u2013133 (2002).","journal-title":"Nat. Neurosci."},{"key":"2191_CR37","first-page":"545","volume":"3","author":"T Olender","year":"2004","unstructured":"Olender, T., Feldmesser, E., Atarot, T., Eisenstein, M. & Lancet, D. The olfactory receptor universe\u2013from whole genome analysis to structure and evolution. Genet. Mol. Res. 3, 545\u2013553 (2004).","journal-title":"Genet. Mol. Res."},{"key":"2191_CR38","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s10020-022-00572-8","volume":"28","author":"D Weidinger","year":"2022","unstructured":"Weidinger, D. et al. OR2AT4 and OR1A2 counterregulate molecular pathophysiological processes of steroid-resistant inflammatory lung diseases in human alveolar macrophages. Mol. Med. 28, 150 (2022).","journal-title":"Mol. Med."},{"key":"2191_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson, M. T., Janaki-Raman, S. & Schulze, A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 31, 62\u201376 (2020).","journal-title":"Cell Metab."},{"key":"2191_CR40","doi-asserted-by":"crossref","unstructured":"Marelli, G. et al. Lipid-loaded macrophages as new therapeutic target in cancer. J. Immunother. Cancer 10, e004584 (2022).","DOI":"10.1136\/jitc-2022-004584"},{"key":"2191_CR41","doi-asserted-by":"publisher","first-page":"20874","DOI":"10.1038\/s41598-023-48116-2","volume":"13","author":"S Batchu","year":"2023","unstructured":"Batchu, S., Hanafy, K. A., Redjal, N., Godil, S. S. & Thomas, A. J. Single-cell analysis reveals diversity of tumor-associated macrophages and their interactions with T lymphocytes in glioblastoma. Sci. Rep. 13, 20874 (2023).","journal-title":"Sci. Rep."},{"key":"2191_CR42","doi-asserted-by":"crossref","unstructured":"Masetti, M. et al. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J. Exp. Med. 219, e20210564 (2022).","DOI":"10.1084\/jem.20210564"},{"key":"2191_CR43","doi-asserted-by":"publisher","unstructured":"Marelli, G. et al. Dataset related to article \u201cChemosensor receptors are lipid-detecting regulators of macrophage functions in cancer\u201d. Zenodo https:\/\/doi.org\/10.5281\/zenodo.15309075 (2025).","DOI":"10.5281\/zenodo.15309075"},{"key":"2191_CR44","doi-asserted-by":"publisher","unstructured":"Marelli, G. et al. Dataset related to article \u201cCRISPR genome-wide screening reveals chemosensor receptors as lipid-detecting regulators of macrophage functions in cancer\u201d Zenodo https:\/\/doi.org\/10.5281\/zenodo.10908256 (2025).","DOI":"10.5281\/zenodo.10908256"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02191-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T13:48:17Z","timestamp":1751291297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-025-02191-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2191"],"URL":"https:\/\/doi.org\/10.1038\/s41590-025-02191-x","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.L. received research funding from Bristol Myers Squibb unrelated to this study and consulting fees from Swarm Therapeutics, Menarini, Amgen, Pfizer and BioLegend. F.B. has received institutional research funds from ADC Therapeutics, Bayer AG, BeiGene, Floratek Pharma, Helsinn, HTG Molecular Diagnostics, Ideogen AG, Idorsia Pharmaceuticals Ltd., Immagene, ImmunoGen, Menarini Ricerche, Nordic Nanovector ASA, Oncternal Therapeutics and Spexis AG; consultancy fees from BIMINI Biotech, Floratek Pharma, Helsinn, Immagene, Menarini and Vrise Therapeutics; advisory board fees to the institution from Novartis. F.B. has also provided expert statements to HTG Molecular Diagnostics and has received travel grants from Amgen, Astra Zeneca and iOnctura. H.M. has received royalties from Chemcom, research grants from Givaudan and consultant fees from Kao. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}